Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Deliveroo sees FY core profit in upper half of guided range after strong H1

(Sharecast News) - Deliveroo said on Thursday that full-year core profit was set to be in the upper half of its guided range following a strong first-half performance. In the six months to 30 June, orders rose 8% to £147m, with revenue also 8% higher, at £1.05bn. Gross transaction value picked up 9% to £3.8bn.

Adjusted earnings before interest, tax, depreciation and amortisation grew 46% to £96.3m. However, the company reported a loss of £19.2m, versus a profit of £1.3m in the same period a year earlier.

Deliveroo - which agreed earlier this year to be bought by US rival DoorDash for £2.9bn - said this was mainly due to higher exceptional items relating to costs associated with the acquisition.

As far as the outlook is concerned, the company narrowed its guidance range for GTV growth to around the top end of the previously-guided range of high single-digits percentage growth in constant currency.

It also said it now expects adjusted EBITDA to be in the upper half of the previously-guided range of £170m to £190m.

Founder and chief executive Will Shu said: "The first half of this year was very positive. Our long term focus on improving the CVP is paying off. Consumer engagement is encouraging, with order frequency and retention continuing to improve across all cohorts.

"Today, both growth and profitability are accelerating. We are delivering on our mission to change the way people shop and eat and to bring the neighbourhood to people's doors. I'm proud of where we are and all that we have achieved. We helped to build an entire sector and have redefined it multiple times over.

"I'm excited for what the partnership with DoorDash can bring in the future. They will be an excellent partner for everyone at the company, as well as for our consumers, merchant partners and riders."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.